2 years ago
MRNA
AnalystsEmmanuel PapadakisEmmanuel Papadakis's Stock Forecasts
AnalystsEmmanuel Papadakis
Analyst Ranking
Bottom 20%
#3673 out of 4565 analysts
Average Return
-9.72%
Win Rate
33%2 out of 6
Risk vs Reward
Poor
Good
Emmanuel Papadakis Analyst Color
Get additional color on Emmanuel Papadakis's coverage of popular stocks
Emmanuel Papadakis's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Moderna IncMRNA | 5 | Hold | $125.00 | +17.72% | Downgrades | 9 months ago |
Biontech SeBNTX | 7 | Hold | $120.00 | +38.39% | Maintains | a year ago |
AlvotechALVO | 2 | Hold | $12.00 | N/A | Maintains | a year ago |
SanofiSNY | 3 | Hold | N/A | N/A | Upgrades | 2 years ago |
Curevac NvCVAC | 1 | Hold | $35.00 | N/A | Initiates Coverage On | 3 years ago |
Novartis AgNVS | 4 | Strong Sell | N/A | N/A | Downgrades | 3 years ago |
Argenx SeARGX | 1 | Hold | N/A | N/A | Initiates Coverage On | 3 years ago |
Ucb SaUCBJY | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 3 years ago |
Roche Holding LtdRHHBY | 1 | Strong Buy | N/A | N/A | Upgrades | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.